Posted by Michael Wonder on 26 Jun 2025
Grace Therapeutics announces submission of new drug application to US FDA for GTx-104
25 June 2025 - Comprehensive data package includes positive results from Phase 3 STRIVE-ON safety trial of GTx-104.
Grace Therapeutics today announced the submission to the US FDA of the Company’s new drug application for GTx-104.
